All of the following are true regarding LMWH (Low Molecular Weight Heparin) except :: (A) It has higher and predictable bioavailability, (B) It inhibits both factor IIa and Xa, (C) PT; aPTT monitoring is not required, (D) It has more favorable pharmacokinetics
Answer is B. None